Advertisement

Ads Placeholder
Loading...

Mereo BioPharma Group plc

MREO•NASDAQ
Healthcare
Biotechnology
$0.32
$-0.01(-3.03%)
U.S. Market opens in 41h 51m

Mereo BioPharma Group plc (MREO) Stock Overview

Explore Mereo BioPharma Group plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap51.1M
P/E Ratio-1.22
EPS (TTM)$-0.25
ROE-0.83%
Fundamental Analysis

AI Price Forecasts

1 Month$0.60
3 Months$1.11
1 Year Target$0.00

MREO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mereo BioPharma Group plc (MREO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.22 and a market capitalization of 51.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.03%
5-Day Change
-4.76%
1-Month Change
-21.95%
3-Month Change
-37.30%
6-Month Change
-84.31%
Year-to-Date (YTD) Change
-37.30%
1-Year Change
-85.52%
3-Year Change
-59.33%
5-Year Change
-91.47%
All-Time (Max) Change
-95.08%

Contact Information

https://www.mereobiopharma.com
44 33 3023 7300
One Cavendish Place, London, NaN, W1G 0QF

Company Facts

360 Employees
IPO DateApr 24, 2019
CountryGB
Actively Trading

Frequently Asked Questions